Trends in systemic glucocorticoid utilization in the United Kingdom from 1990 to 2019 : a population-based, serial cross-sectional analysis
| dc.contributor.author | Menzies-Gow, Andrew | |
| dc.contributor.author | Tran, Trung N | |
| dc.contributor.author | Stanley, Brooklyn | |
| dc.contributor.author | Carter, Victoria Ann | |
| dc.contributor.author | Smolen, Josef S | |
| dc.contributor.author | Bourdin, Arnaud | |
| dc.contributor.author | FitzGerald, J. Mark | |
| dc.contributor.author | Raine, Tim | |
| dc.contributor.author | Chapaneri, Jatin | |
| dc.contributor.author | Emmanuel, Benjamin | |
| dc.contributor.author | Jackson, David J | |
| dc.contributor.author | Price, David | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-03-18T11:18:01Z | |
| dc.date.available | 2024-03-18T11:18:01Z | |
| dc.date.issued | 2024-03-15 | |
| dc.description | Acknowledgments The authors thank the members of the Forum for reducing Oral Corticosteroid Use in Severe asthma (FOCUS) for their involvement in the conception of the study (Table S5). Medical writing support, including preparation of the draft manuscript under the direction and guidance of the authors, incorporating author feedback, and manuscript submission, was provided by Lea Anne Gardner, PhD, RN (CiTRUS Health Group), in accordance with Good Publication Practice 2022 (GPP 2022) guidelines. This support was funded by AstraZeneca (Cambridge, UK). Data from OPCRD were obtained under license from Optimum Patient Care Limited. The interpretation and conclusions contained in this report are those of the authors alone. Funding This work was funded by AstraZeneca. In collaboration with the steering committee, AstraZeneca was involved in the study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the article for publication. All authors had full access to the data, agreed to be accountable for the accuracy and integrity of the work, and shared responsibility for the decision to submit the article for publication. Steering committee members were not compensated for their participation. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 1594951 | |
| dc.identifier | 284513734 | |
| dc.identifier | 7f7f9bbc-2215-4276-81f8-3fb478d67772 | |
| dc.identifier.citation | Menzies-Gow, A, Tran, T N, Stanley, B, Carter, V A, Smolen, J S, Bourdin, A, FitzGerald, J M, Raine, T, Chapaneri, J, Emmanuel, B, Jackson, D J & Price, D 2024, 'Trends in systemic glucocorticoid utilization in the United Kingdom from 1990 to 2019 : a population-based, serial cross-sectional analysis', Pragmatic and Observational Research, vol. 2024, no. 15, pp. 53-64. https://doi.org/10.2147/POR.S442959 | en |
| dc.identifier.doi | 10.2147/POR.S442959 | |
| dc.identifier.iss | 15 | en |
| dc.identifier.issn | 1179-7266 | |
| dc.identifier.uri | https://hdl.handle.net/2164/23046 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Pragmatic and Observational Research | en |
| dc.subject | Glucocorticoids | en |
| dc.subject | Practice Patterns | en |
| dc.subject | Drug prescriptions | en |
| dc.subject | Biological products | en |
| dc.subject | Drug utilization | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Trends in systemic glucocorticoid utilization in the United Kingdom from 1990 to 2019 : a population-based, serial cross-sectional analysis | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Menzies_etal_POR_Trends_In_Systemic_VoR.pdf
- Size:
- 1.52 MB
- Format:
- Adobe Portable Document Format
